Human Reproduction, Vol. 14, No. 3, 864-865,
March 1999
© 1999 European Society of Human Reproduction and Embryology
Letters to the Editor |
Ovarian stimulation
Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot 76100, Israel
Dear Sir,
This is with reference to the article by Devroey et al. (1998) on the use of 100 IU of recombinant follicle stimulating hormone (FSH) as a starting dose for ovarian stimulation for in-vitro fertilization (IVF) and embryo transfer. The authors stated that `The possibility of lowering starting doses might therefore contribute to decreased exposure of medication, lower incidence of unwanted over-stimulation and therefore lower treatment costs'. This statement is
References
Centre for Reproductive Medicine, Academic Hospital, Dutch Speaking Free University, Laarbeeklaan 101, Brussels, Belgium
NV Organon, PO Box 20, 5340 BH Oss, The Netherlands